Croda International (CRDAN) Stock Price & Analysis
CRDAN Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- MXN 128.02B
- Enterprise Value
- MXN 4.82B
- Total Cash (Recent Filing)
- MXN 205.30M
- Total Debt (Recent Filing)
- MXN 783.20M
- Price to Earnings (P/E)
- 64.4
- Beta
- N/A
- Next Earnings
- Feb 23, 2027 (Est.)
- EPS Estimate
- 17.46
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Differentiated Specialty-chemicals Model
Croda’s focus on high-performance, formulation-critical ingredients differentiates it from commodity chemical suppliers. Products embedded in customer formulations, supported by technical expertise and innovation, can encourage repeat demand and help sustain premium economics over the next several quarters.
Organic Growth And Margin Expansion
Recent operating progress shows that growth is translating into improved profitability rather than relying solely on volume. Reiterated 2026 organic growth guidance and planned sequential margin improvement provide a constructive foundation for earnings recovery over the medium term.
Manageable Leverage And Positive Cash Generation
Consistently positive operating cash flow and free cash flow give Croda internal funding capacity for investment, dividends, and balance-sheet needs. Manageable leverage and a sizable equity base further improve financial resilience if trading conditions remain uneven.
Bears Say
Post-2022 Earnings Normalization
The sharp normalization from unusually strong 2022 earnings indicates that Croda’s recent profit base has not yet demonstrated consistent upward momentum. Volatile revenue and only a modest 2025 rebound could constrain earnings compounding until recovery becomes more durable.
Working-capital Pressure On Cash Conversion
A substantial working-capital outflow reduces the cash benefit of operating profit and can make reported earnings less reliable as a funding source. Management expects structural improvements, but the program is phased into 2027–2028, leaving an interim drag on liquidity efficiency.
Uneven Segment And Input-cost Conditions
Weakness in Crop Protection and uneven Pharma Solutions project timing create a less predictable revenue mix across Croda’s end markets. Continued input-cost inflation also requires selective pricing actions, which may pressure margins when customer pass-through is delayed.
Croda International News
CRDAN FAQ
What is Croda International’s market cap?
When is Croda International’s upcoming earnings report date?
How were Croda International’s earnings last quarter?
Is Croda International overvalued?
Does Croda International pay dividends?
What is Croda International’s EPS estimate?
How many shares outstanding does Croda International have?
What happened to Croda International’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Croda International?
What is the TipRanks Smart Score and how is it calculated?
Croda International Stock Smart Score
Company Description
Croda International
Croda International Plc, established in 1925 and headquartered in Goole, United Kingdom, is a global leader in the development, manufacture, and supply of high-performance specialty chemicals. The company serves a diverse international client base across Europe, the Middle East, Africa, North America, Asia, and Latin America. Its operations are organized into four primary business segments: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. Croda's extensive product portfolio addresses a wide array of industrial and consumer needs. For the Consumer Care market, it delivers crucial ingredients for personal care products, spanning skin, hair, sun, and baby care, along with solutions for color cosmetics, oral hygiene, self-tanning, deodorants, men's grooming, and depilatories, as well as household and institutional cleaning formulations. In Life Sciences, the company provides innovative solutions for agriculture, including crop protection additives, seed enhancements, animal health chemicals, and bio-stimulants, alongside dietary supplements and active pharmaceutical ingredients. The Performance Technologies and Industrial Chemicals segments encompass a vast range of specialized materials. This includes additives for lubricants, coatings, polymers, batteries, and catalysts; materials for electronics, construction, and thermal management; adhesives; and chemicals for vehicle cleaning, automotive textiles, and plastic/rubber products. Furthermore, Croda supplies chemicals for packaging, printing, paper, paints, and water treatment, along with oleochemicals, emulsifiers, fuel additives, and specialty polymer additives for furniture and wood. The company also innovates in bio-based phase change materials, offering solutions for temperature control in buildings, clothing, healthcare, electronics, food refrigeration, energy storage, packaging, and automotive applications. This broad offering underscores Croda's commitment to delivering specialized chemical solutions across numerous critical industries.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Stephen Edward Foots
- Employees
- 5,954
- Website
- www.croda.com
- Address
- Cowick Hall, Goole, YO, DN14 9AA, GB
Croda International (CRDAN) Earnings & Revenues
CRDAN Earnings Call
Earnings Call SentimentPositive
The call presented a broadly positive operational and financial picture: organic growth, margin expansion, improved EPS and cash flow, strong outperformance in Consumer Care (notably Beauty Actives) and progress on transformation and AI initiatives. Headwinds remain in certain areas — Pharma Solutions phasing and lumpiness, Crop Protection weakness, regional F&F disruption, working-capital outflow and input-cost volatility — but management reiterated FY guidance and a clear path to their 3-year targets, viewing many challenges as within management control.
View all MX:CRDAN earnings summaries